Wealth Enhancement Advisory Services, LLC Editas Medicine, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 45,017 shares of EDIT stock, worth $97,236. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,017
Previous 18,416
144.45%
Holding current value
$97,236
Previous $23,000
126.09%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EDIT
# of Institutions
218Shares Held
48.4MCall Options Held
436KPut Options Held
324K-
Black Rock Inc. New York, NY7.78MShares$16.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.47MShares$16.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$5.74 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.6MShares$5.62 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.94MShares$4.2 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $148M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...